enVVeno Medical

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NVNO and other ETFs, options, and stocks.

About NVNO

enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. 

CEO
Robert Andrew Berman
CEORobert Andrew Berman
Employees
24
Employees24
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
1999
Founded1999
Employees
24
Employees24

NVNO Key Statistics

Market cap
59.52M
Market cap59.52M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
48.73K
Average volume48.73K
High today
$6.48
High today$6.48
Low today
$6.28
Low today$6.28
Open price
$6.39
Open price$6.39
Volume
20.19K
Volume20.19K
52 Week high
$10.70
52 Week high$10.70
52 Week low
$3.35
52 Week low$3.35

NVNO Earnings

-$0.94
-$0.63
-$0.31
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 10, Pre-Market
ActualExpected Nov 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.